Free Trial
NASDAQ:ACOG

Alpha Cognition Q2 2025 Earnings Report

Alpha Cognition logo
$8.60 -1.39 (-13.91%)
As of 02:38 PM Eastern
Upcoming Event
Earnings Conference Call
Alpha Cognition Q2 2025
00:00 / 00:00
Live Transcript
Follow Audio

Alpha Cognition EPS Results

Actual EPS
N/A
Consensus EPS
-$0.84
Beat/Miss
N/A
One Year Ago EPS
N/A

Alpha Cognition Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.32 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Alpha Cognition Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Alpha Cognition Earnings Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Alpha Cognition (ACOG) Projected to Post Quarterly Earnings on Thursday
See More Alpha Cognition Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Cognition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Cognition and other key companies, straight to your email.

About Alpha Cognition

Alpha Cognition (NASDAQ:ACOG), Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

View Alpha Cognition Profile

More Earnings Resources from MarketBeat